Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
05/2007
05/02/2007EP1255769B1 Universal procedure for refolding recombinant proteins
05/02/2007EP0869968B1 Growth-hormone secretagogues
05/02/2007CN1956994A Epithelial cell growth promoter
05/02/2007CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
05/01/2007USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening
05/01/2007US7211566 a nonapeptide analog; antiinflammatory, antidiabetic agents, analgesics, antiastmatic agents
05/01/2007US7211409 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin
05/01/2007US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand
05/01/2007CA2185394C Biotinderivate
04/2007
04/26/2007WO2007045184A1 The peptides essence receptor antagonist which 2-site containing proline or crico-amino acid
04/26/2007WO2007025307A3 Inhibitors of serine proteases
04/26/2007WO2007005733A3 Novel peptides promoting neurite outgrowth
04/26/2007WO2005005612A3 Tag-1 and tag-2 proteins and uses thereof
04/26/2007US20070093664 Process for the production of lisinopril
04/26/2007US20070093663 Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof.
04/26/2007US20070093649 Process for purifying interferon beta
04/26/2007US20070093430 Interferons; polyoxyethylene glycol
04/26/2007US20070093425 Improved safety and stability and excellent percutaneous permeability; 6-(succinyl-glycyl-histidyl-lysine)ascorbic acid; cosmetics; for topical application to the skin
04/26/2007US20070093414 Hepatitis C virus inhibitors
04/26/2007US20070093413 Histone deacetylases, and uses related thereto
04/25/2007EP1776130A2 Pin1-modulating compounds and methods of use thereof
04/25/2007EP1478652B1 Components for producing amphoteric liposomes
04/25/2007CN1953988A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides
04/25/2007CN1951955A Peptide-like endothelin receptor antagonist with proline or cyclic amino acid on 2-postion
04/25/2007CN1951954A Preparation method for pro-his cyclic dipeptide
04/25/2007CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
04/25/2007CN1312140C Lipid lowering biphenylcarboxamides
04/24/2007US7208607 Reaction of 2-bromophenylalaninate with diisopropylethylamine and (2R)-2-bromopropionyl chloride and reaction of product with ethyl (2S)-2-aminopentanoate, triethylamine and acetonitrile, and hydrogenation of product; new process uses readily obtainable starting materials
04/24/2007US7208600 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
04/24/2007US7208525 Diagnostic agents for pancreatic exocrine function
04/24/2007US7208149 IL-16 antagonist peptides and DNA encoding the peptides
04/24/2007CA2234610C New amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
04/24/2007CA2151933C A proteinase inhibitor, precursor thereof and genetic sequences encoding same
04/19/2007WO2007042274A1 Salt enhancing compounds and use
04/19/2007WO2006116541A3 Tat-002 and methods of assessing and treating cancer
04/19/2007WO2004058189A3 Chemokine antagonists and uses thereof
04/19/2007US20070088168 Reaction of benzyl (2S)-2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylate with triethylamine and then (2S)-2-[(tert-butoxycarbonyl)amino]propionyl chloride and reaction of product with ethyl 2-oxopentanoate and hydrogenation using platinum on carbon catalyst
04/19/2007US20070087409 Angiotensin peptide-carrier conjugates and uses thereof
04/18/2007EP1773869A1 Macrocyclic modulators of the ghrelin receptor
04/18/2007EP1773868A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
04/18/2007EP1773386A2 Vaccine compositions and methods
04/18/2007EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics
04/18/2007EP1276718B1 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
04/18/2007EP0984001B1 4-organothio-2-cyclopentenones and 3-organothio-2-cyclopentanones, production and pharmaceutical uses thereof
04/18/2007CN1950393A Novel inhibitors of hepatitis c virus ns3 protease
04/18/2007CN1311238C Hypotensors
04/17/2007US7205435 Type B botulism toxin inhibitors
04/17/2007US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor
04/17/2007US7205387 polypeptide comprises a hairpin motif of a neurotrophin
04/17/2007US7205383 Peptide ligands of leukocyte integrins
04/17/2007US7205382 Solid phase synthesis; for autoimmune diseases, rheumatoid diseases, multiple sclerosis, and myasthenia gravis
04/17/2007US7205336 β-secretase inhibitors
04/17/2007US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide
04/17/2007US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives
04/17/2007US7205120 Detection Alzheimer's disease
04/17/2007US7204972 Annexin derivatives with endogenous chelation sites
04/17/2007CA2133205C Stable polypeptide composition
04/17/2007CA2123912C Muramyl compounds for treatment of septic shock
04/12/2007WO2006137974A3 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
04/12/2007WO2006128455A3 Compounds modifying apoptosis
04/12/2007US20070083052 Process for synthesis of perindopril and pharmaceutically acceptable salts thereof.
04/12/2007US20070082878 Cytotoxic depsipeptides
04/12/2007US20070082839 Peptide increasing fusiogenic capacity of a gamete
04/11/2007EP1771731A2 Detection of truncation mutations by mass spectrometry
04/11/2007EP1771456A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent
04/11/2007EP1730313A4 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents
04/11/2007EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof
04/11/2007EP1015439B1 Prenyl transferase inhibitors
04/11/2007CN1946847A Process for producing dipeptide
04/11/2007CN1946743A Hyaluronic acid/methotrexate compound
04/11/2007CN1946737A Functional method for generating or screening for ligands which modulate steroid hormone receptors
04/11/2007CN1946718A Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
04/11/2007CN1946692A 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
04/11/2007CN1946691A Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
04/11/2007CN1946690A Cyclobutenedione groups-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
04/11/2007CN1944457A Glutathione calcium chelate and its preparing method, use and composition
04/11/2007CN1309413C Tetrapeptide derivative crystals
04/10/2007US7202338 PRO731 polypeptides
04/10/2007US7202337 Polypeptide encoded by a nucleic acid overexpressed in esophageal tumor, normal stomach and melanoma
04/10/2007US7202336 Polypeptide encoded by a nucleic acid overexpressed in kidney tumor and underexpressed in lung tumor
04/10/2007US7202335 Antibody which binds to the specific polypeptide is monoclonal, humanized, labeled or fragment
04/10/2007US7202332 Methods for preparing internally constrained peptides and peptidomimetics
04/10/2007US7202330 RGD (Arg-Gly-Asp) coupled to (neuro)peptides
04/10/2007US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
04/10/2007US7202269 GlyT2 modulators
04/10/2007US7202258 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
04/10/2007US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents
04/10/2007US7201903 Method and device for detecting feline immunodeficiency virus
04/10/2007CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them
04/10/2007CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them
04/10/2007CA2148194C Cyclopeptides of the formula i
04/05/2007WO2007038772A1 Novel drugs for dementia
04/05/2007WO2007020386A3 Apoe mimetic agents
04/05/2007WO2007007060A3 N- or c- terminally modified small peptides
04/05/2007WO2006105201A3 Conjugates comprised of fatty acid and hiv gp41-derived peptide
04/05/2007WO2006101858B1 Alpha-helix mimetics and methods relating to the treatment of fibrosis
04/05/2007WO2003070751A3 Partial peptide mimetics and methods
04/05/2007US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
04/05/2007US20070078094 Guanidinium delivery carriers
04/05/2007US20070078081 Antiviral compounds
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 307